ACAD icon

Acadia Pharmaceuticals
ACAD

Overview Fund Activity

245 hedge funds and large institutions have $2.12B invested in Acadia Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 88 reducing their positions, and 47 closing their positions.

Holders
245
Holders Change
-17
Holders Change %
-6.49%
% of All Funds
4.14%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
36
Increased
69
Reduced
88
Closed
47
Calls
$25.3M
Puts
$17.4M
Net Calls
+$7.88M
Net Calls Change
-$10.4M

Top Buyers

1
RI
1
RTW Investments
New York
$59.5M
2
Morgan Stanley
2
Morgan Stanley
New York
$44M
3
DTC
3
Deep Track Capital
Connecticut
$24.4M
4
State Street
4
State Street
Massachusetts
$92.9M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$10.8M

Top Sellers

1
ACA
1
Avoro Capital Advisors
New York
$0
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$348K
3
TP
3
Thunderbird Partners
United Kingdom
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$175M
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$0
Name Market Value Shares Shares
Change 		Shares
Change %
EA
26
Emerald Advisers
Pennsylvania
$12.1M 860,749 +72,011 +9%
Millennium Management
27
Millennium Management
New York
$12M 854,277 -232,612 -21%
PAMS
28
Pictet Asset Management (Switzerland)
Switzerland
$11.9M 847,964 +395,959 +88%
EMFAT
29
Emerald Mutual Fund Advisers Trust
Pennsylvania
$10.8M 766,971 +116,978 +18%
Wellington Management Group
30
Wellington Management Group
Massachusetts
$10.8M 763,591 +763,591 New
FFM
31
Fairmount Funds Management
Pennsylvania
$10.6M 751,804 -405,013 -35%
FC
32
Finepoint Capital
Massachusetts
$9.96M 707,200 +707,200 New
LGM
33
Logos Global Management
California
$9.16M 650,000 +650,000 New
PAM
34
Panagora Asset Management
Massachusetts
$9.11M 646,767 +166,885 +35%
Nordea Investment Management
35
Nordea Investment Management
Sweden
$8.89M 630,080 +10,555 +2%
UBS AM
36
UBS AM
Illinois
$8.66M 614,537 +42,192 +7%
BCLSI
37
Bain Capital Life Sciences Investors
Massachusetts
$8.46M 600,523 +600,523 New
FCM
38
Frontier Capital Management
Massachusetts
$7.98M 566,323 -312,667 -36%
RHJA
39
Rice Hall James & Associates
California
$7.66M 543,528 +80,224 +17%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$6.97M 494,809 -14,980 -3%
Squarepoint
41
Squarepoint
New York
$6.97M 494,702 +295,079 +148%
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$6.95M 492,928 -148,295 -23%
Invesco
43
Invesco
Georgia
$6.34M 449,694 -26,172 -5%
Rockefeller Capital Management
44
Rockefeller Capital Management
New York
$6.13M 435,235 +117,500 +37%
Bank of America
45
Bank of America
North Carolina
$5.51M 390,793 -109,580 -22%
PHS
46
PFM Health Sciences
California
$5.43M 384,995 +384,995 New
VOYA Investment Management
47
VOYA Investment Management
Georgia
$4.52M 320,926 +272,673 +565%
Artisan Partners
48
Artisan Partners
Wisconsin
$4.46M 316,293 -910,678 -74%
Citadel Advisors
49
Citadel Advisors
Florida
$4.22M 299,297 -117,641 -28%
Swiss National Bank
50
Swiss National Bank
Switzerland
$4.02M 285,104 – –
1
2
3 4 5